This case summarises events leading to the creation of a global giant. The merger of Glaxo Wellcome and SmithKline Beecham had implications that went beyond the UK, where both companies were domiciled. The new company sought to take residence in the US but anti-trust authorities kept the companies formally apart for more than a year as they examined every aspect of the deal. The case invites readers to consider the process of integration as a general strategy, as well as the expectations, deliberations and motivation of managers and shareholders in doing so.
Download Info
To download:
If you experience problems downloading a file, check if you have the
proper application to
view it first. Information about this may be contained
in the File-Format links below. In case of further problems read
the IDEAS help
page. Note that these files are not on the IDEAS
site. Please be patient as the files may be large.